Commentary on H. Ide et al., "Tyk2 expression and its signaling enhances the invasiveness of prostate cancer cells"

Biochemical and Biophysical Research Communications

Volumn 366, Issue 4, 2008, Pages 869-870

  Schuster, Christian ^a   Müller, Mathias ^b   Freissmuth, Michael ^a   Sexl, Veronika ^a   Stoiber, Dagmar ^a,c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; PROTEIN KINASE TYK2; SMALL INTERFERING RNA;

B CELL LYMPHOMA; BURKITT LYMPHOMA; CANCER CELL; CANCER INVASION; CELL INFILTRATION; DOWN REGULATION; ENZYME INHIBITION; GENOTYPE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; SHORT SURVEY; SIGNAL TRANSDUCTION;

ANIMALS; BURKITT LYMPHOMA; HUMANS; LIVER; MALE; MICE; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS; PROTEIN KINASE INHIBITORS; SIGNAL TRANSDUCTION; TYK2 KINASE;

EID: 37549022298     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.12.017     Document Type: Short Survey

References (13)

1. Ide H., Nakagawa T., Terado Y., Kamiyama Y., Muto S., and Horie S. Tyk2 expression and its signaling enhances the invasiveness of prostate cancer cells. Biochem. Biophys. Res. Commun. (2007)
2. Adams J.M., Harris A.W., Pinkert C.A., Corcoran L.M., Alexander W.S., Cory S., Palmiter R.D., and Brinster R.L. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318 (1985) 533-538
3. Harris A.W., Pinkert C.A., Crawford M., Langdon W.Y., Brinster R.L., and Adams J.M. The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells. J. Exp. Med. 167 (1988) 353-371
4. Sidman C.L., Denial T.M., Marshall J.D., and Roths J.B. Multiple mechanisms of tumorigenesis in E mu-myc transgenic mice. Cancer Res. 53 (1993) 1665-1669
5. Sidman C.L., Shaffer D.J., Jacobsen K., Vargas S.R., and Osmond D.G. Cell populations during tumorigenesis in E mu-myc transgenic mice. Leukemia 7 (1993) 887-895
6. Langdon W.Y., Harris A.W., Cory S., and Adams J.M. The c-myc oncogene perturbs B lymphocyte development in E-mu-myc transgenic mice. Cell 47 (1986) 11-18
7. Karaghiosoff M., Neubauer H., Lassnig C., Kovarik P., Schindler H., Pircher H., McCoy B., Bogdan C., Decker T., Brem G., Pfeffer K., and Muller M. Partial impairment of cytokine responses in Tyk2-deficient mice. Immunity 13 (2000) 549-560
8. Mellado M., Rodriguez-Frade J.M., Manes S., and Martinez A.C. Chemokine signaling and functional responses: the role of receptor dimerization and TK pathway activation. Annu. Rev. Immunol. 19 (2001) 397-421
9. Muller A., Homey B., Soto H., Ge N., Catron D., Buchanan M.E., McClanahan T., Murphy E., Yuan W., Wagner S.N., Barrera J.L., Mohar A., Verastegui E., and Zlotnik A. Involvement of chemokine receptors in breast cancer metastasis. Nature 410 (2001) 50-56
10. Wiley H.E., Gonzalez E.B., Maki W., Wu M.T., and Hwang S.T. Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. J. Natl. Cancer Inst. 93 (2001) 1638-1643
11. Li W.Q., Dehnade F., and Zafarullah M. Oncostatin M-induced matrix metalloproteinase and tissue inhibitor of metalloproteinase-3 genes expression in chondrocytes requires Janus kinase/STAT signaling pathway. J. Immunol. 166 (2001) 3491-3498
12. Tsareva S.A., Moriggl R., Corvinus F.M., Wiederanders B., Schutz A., Kovacic B., and Friedrich K. Signal transducer and activator of transcription 3 activation promotes invasive growth of colon carcinomas through matrix metalloproteinase induction. Neoplasia 9 (2007) 279-291
13. Itoh M., Murata T., Suzuki T., Shindoh M., Nakajima K., Imai K., and Yoshida K. Requirement of STAT3 activation for maximal collagenase-1 (MMP-1) induction by epidermal growth factor and malignant characteristics in T24 bladder cancer cells. Oncogene 25 (2006) 1195-1204